Questions from the Cell & Gene Live Audience

During Cell & Gene Live events, we take real-time questions from our audience. Here, Gregory Opiteck, Ph.D., VP Head of Translational Sciences at Allogene Therapeutics and Douglas Sanders, Ph.D., VP Head of Translational Medicine at AVROBIO provide thoughtful, detailed responses to our audience’s questions, including how maneuver a company's infrastructure in order for the biomarker translational groups to collaborate better as well as how to evolve translational approaches in the cell and gene therapy space more confidently into the clinic.